National Natural Science Foundation of China(82170413,82170342,82200377);Guangdong Basic and Applied Basic Research Foundation(2021A1515012546,2022A1515012474);Shanghai Yangfan Project(21YF1440000);Innovation Team of General Universities in Guangdong Province(2023KCXTD025);Guangzhou Science and Technology Plan(202102010101,202201020220);Student Innovation Program of Guangzhou Medical University(to S.J.L.).
The commercially available drug-eluting stent with limus (rapamycin, everolimus, etc.) or paclitaxel inhibits smooth muscle cell (SMC), reducing the in-stent restenosis, whereas damages endothelial cell (EC) and delay...
目的:研究分析可溶性内皮细胞蛋白C受体(Endothelial cell protein C receptor,sEPCR)与膜型EPCR(mEPCR)在参与类风湿关节炎(Rheumatoid Arthritis,RA)疾病进展中的作用。方法:在DBA1/J小鼠尾部注射II型胶原蛋白诱导关节炎小鼠(CIA小鼠)...
目的:构建稳定敲低人内皮细胞蛋白C受体(endothelial cell protein C receptor,EPCR)的人脐带间充质干细胞(human umbilical cord mesenchymal stem cells,hUC-MSCs),检测敲低EPCR对hUC-MSCs向成纤维细胞分化能力的影响。方法:根据EPCR...